Chronic inflammation

There are 27,258 papers on chronic inflammation in aging research: 1,880 trials and 6,338 observational studies in people, 9,016 in animals, 1,387 in cells, 8,011 reviews. The newest story, Nov 16, 2026: “One inflammation marker was slightly higher in older adults”.

Hallmark of agingLópez-Otín 2023

27,258 papers study it7,159 more mention it8,600 findings

1,846 new papers in 30 daysSee all 34,417 papers on chronic inflammation

At a glance

Inflammation is linked with higher mortality in people with chronic kidney disease; a cross-sectional human study links it with smaller hippocampal volume. Aerobic exercise reduces hippocampal inflammation in naturally aging male mice. A human trial reports reduced type I interferon signaling with metformin, while another finds no clear inflammation change with exercise and cognitive-behavioral training.

8,600 findings in 7,628 papers from 1987 to 2026, 1,201 of them since April 2026

“Metabolic unhealthiness and low-grade inflammation partially mediated the associations between body size and RA risk.”
Child-to-adult body size trajectories and risk of rheumatoid arthritis: the mediating role of metabolic unhealthiness, low-grade inflammation, and the modifying effect of genetic susceptibilityJournal of autoimmunity2026doi:10.1016/j.jaut.2026.103612
  • Human trial1,880
  • Humans6,338
  • Animals8,874
  • Model organisms142
  • Cells1,387
  • In silico343

Interventions

280

GLP-1 receptor agonists

downin reviews19downin humans4

23 studies
  1. GLP-1 receptor agonists decrease inflammation (epilepsy).

    “GLP-1 RAs affect several mechanisms shared with adenosine signaling. These include reduction of astrogliosis, neuroinflammation, and mTOR activity”

    Reviewepilepsy

    Convergent mechanisms between GLP-1 and adenosine in epilepsy: opportunities for therapeutic exploitation?

    Brain research bulletin

  2. GLP-1 receptor agonists decrease inflammation (selected preclinical infection models).

    “Across selected preclinical models, GLP-1RAs more consistently attenuate inflammation and tissue injury while preserving organ function”

    Reviewselected preclinical infection models

    GLP-1/GLP-1R signalling in infectious diseases: basic biology, immunometabolic mechanisms, and therapeutic translation

    Molecular biomedicine

  3. GLP-1 receptor agonists decrease inflammation (obesity and type 2 diabetes).

    “appear to reduce the systemic low-grade inflammation of obesity and type 2 diabetes”

    Reviewobesity and type 2 diabetes

    GLP-1 based therapy of obesity and type 2 diabetes

    Diabetology international

  4. GLP-1 receptor agonists decrease inflammation (neurodegenerative diseases).

    “The results revealed promising mechanisms related to reductions in neuroinflammation, oxidative stress, and mitochondrial dysfunction, as well as possible benefits for neuronal integrity.”

    Reviewneurodegenerative diseases

    GLP-1 agonists as potential neuroprotective agents: advances and prospects in the treatment of neurodegenerative diseases

    Brazilian Journal of One Health

  5. GLP-1 receptor agonists decrease inflammation (preclinical models of inflammatory bowel disease).

    “Experimental studies generally support anti-inflammatory and mucosal-protective effects in preclinical models”

    Reviewpreclinical models of inflammatory bowel disease

    Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: From Metabolic Regulation to Immunomodulation Along the Gut–Immune–Metabolic Axis

    Biomedicines

  6. GLP-1 receptor agonists decrease inflammation (experimental evidence).

    “Experimental findings suggested anti-inflammatory, antioxidant, and osteogenic effects, but molecular responses were not consistently accompanied by structural benefits.”

    Reviewexperimental evidence

    Beyond Glycemic Control: Periodontal, Salivary, and Oral Microbiome Effects of GLP-1 Receptor Agonists—A Scoping Review of Clinical and Preclinical Evidence

    Pharmaceutics

  7. GLP-1 receptor agonists decrease inflammation in humans (metabolic dysfunction-associated steatotic liver disease).

    “GLP-1 RAs improved hepatic steatosis and inflammation”

    Reviewmetabolic dysfunction-associated steatotic liver diseaseliver

    Beyond weight loss: the long-term effects of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis and fibrosis regression

    International Journal of Research in Medical Sciences

  8. GLP-1 receptor agonists decrease inflammation.

    “alleviate systemic and local neuroinflammation”

    Review

    EXPANDING THERAPEUTIC HORIZONS OF GLP-1 RECEPTOR AGONISTS: FROM METABOLIC REGULATION TO NEUROPROTECTION IN ALZHEIMER’S DISEASE AND ADDICTION DISORDERS – A COMPREHENSIVE REVIEW

    International Journal of Innovative Technologies in Social Science

  9. GLP-1 receptor agonists decrease inflammation (preclinical models).

    “reported beneficial effects (reduced disease severity or delayed onset, with anti-inflammatory and neuroprotective effects) in nine of ten studies.”

    Reviewpreclinical models

    Reported effects of glucagon-like peptide-1 receptor agonists in multiple sclerosis: a scoping review of preclinical and clinical studies

    The Egyptian Journal of Neurology Psychiatry and Neurosurgery

  10. GLP-1 receptor agonists decrease inflammation (preclinical studies).

    “exert neuroprotective effects by reducing amyloid-β and tau accumulation, and reducing neuroinflammation.”

    Reviewpreclinical studies

    GLP-1 Receptor Agonists as Neuroprotective Agents in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

    Carleton undergraduate journal of science.

All 23

More on GLP-1 receptor agonists

Exercise

downin reviews10downin humans7downin mice2downin rats1

20 studies
  1. Exercise decreases inflammation in humans (breast cancer survivors).

    “both AE and HET diminished the inflammatory markers interleukin 1β (IL-1β), interferon-gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and insulin-like growth factor 1 (IGF-1)”

    Human trialbreast cancer survivors16 weeks

    A randomized controlled trial of home-based combined exercise training for improving inflammatory markers and physical function in breast cancer survivors

    Cancer treatment and research communications

  2. Exercise is linked with lower inflammation in humans (regularly exercising versus sedentary individuals).

    “regular exercise enhanced major histocompatibility complex-I/II signaling between APCs and T cells and suppressed inflammatory networks”

    Humansregularly exercising versus sedentary individuals

    Multiomics profiling identifies molecular and cellular signatures of regular exercise in human peripheral blood

    Science advances

  3. Exercise decreases inflammation.

    “exercise training favorably modulates the phenotype and function of these adipose depots by attenuating pro-inflammatory signaling”

    Reviewperivascular and epicardial adipose tissue

    Aerobic exercise and cardiovascular health: insights into perivascular and epicardial adipose tissues

    American journal of physiology. Heart and circulatory physiology

  4. Exercise decreases inflammation (cancer).

    “Regular exercise systematically counteracts tumor-induced homeostatic locking by reprogramming immune metabolism, attenuating chronic inflammation, and improving tissue perfusion.”

    Reviewcancer

    Exercise enhances cancer immunotherapy by reshaping systemic T cell homeostasis

    Translational oncology

  5. Exercise decreases inflammation (Alzheimer's disease).

    “suppresses microglial overactivation and sustained neuroinflammatory responses”

    ReviewAlzheimer's diseasebrain

    Physical exercise: a multi-target strategy for the prevention and treatment of Alzheimer’s disease

    Frontiers in aging neuroscience

  6. Exercise decreases inflammation in type 2 diabetic rats.

    “An increase in pro-inflammatory cytokines, such as IL-1β and TNF-α, was observed in the hippocampus of T2DM animals and was reduced by exercise.”

    Animalsin type 2 diabetic ratshippocampus14 weeks

    Treadmill exercise impedes cognitive decline in type 2 diabetic rats by improving mitochondrial function and modulating the TGF-β/Smad-3 pathway

    Pflugers Archiv : European journal of physiology

  7. Exercise inhibits pyroptosis (Alzheimer's disease).

    “accumulating evidence suggests that exercise serves as an effective non-pharmacological intervention to suppress pyroptosis and alleviate AD”

    ReviewAlzheimer's disease

    Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology

    Frontiers in aging neuroscience

  8. Exercise decreases inflammation (systemic inflammation).

    “regular physical activity has been shown to counteract several deleterious effects of a sedentary lifestyle by reducing systemic inflammation”

    Reviewsystemic inflammation

    Physical activity and improvement of physiological parameters by training

    Frontiers in sports and active living

  9. Exercise decreases inflammation.

    “Exercise opposes this cascade through the AMPK-PGC-1α axis, which coordinately activates four mitochondrial quality control (MQC) modules”

    Reviewrepeated training

    Mitochondrial Quality Control Links Exercise to Sterile Inflammation in the Cardiovascular System: A Narrative Review

    Antioxidants (Basel, Switzerland)

  10. Exercise decreases inflammation in cancer-associated sarcopenia.

    “physical exercise may modulate purinergic signaling and inflammation”

    Reviewin cancer-associated sarcopenia

    Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]

All 20

More on Exercise

Metformin

downin rats3downin reviews3downin human cells2downin humans1+1

10 studies
  1. Metformin decreases type I interferon signaling in humans (z score = −2.4).

    “We found downregulation of interferon α/β signaling (P = 0.003, z score = −2.4, Table 2”

    Human trial18 monthsn = 15

    Metformin trial found no significant blood gene activity changes

    GeroScience

  2. Metformin decreases type I interferon signaling in humans (z score = -2.4).

    “canonical pathway analysis found downregulation of interferon α/β signaling (P = 0.003, z score = -2.4)”

    Human trialsecondary, hypothesis-generating pathway analysis in nondiabetic adults with geographic atrophy due to age-related macular degenerationwhole blood1000 mg twice daily18 monthsn = 15

    Metformin trial found no significant blood gene activity changes

    GeroScience

  3. Metformin inhibits NF-κB signaling in mice (tamoxifen-induced SPEM).

    “KEGG and GSEA analyses revealed that the NF-κB signaling pathway was significantly upregulated in SPEM, and downregulated by metformin.”

    Animalstamoxifen-induced SPEMstomach

    Metformin prevents and accelerates the resolution of spasmolytic polypeptide-expressing metaplasia in mice

    Frontiers in gastroenterology (Lausanne, Switzerland)

  4. Metformin decreases inflammation in the L4-6 SDH of DM rats.

    “metformin intervention reduced the activation levels of microglia and astrocytes in the L4-6 SDH of DM rats”

    Animalsin the L4-6 SDH of DM ratsspinal dorsal horn

    Mechanism by which metformin alleviates neuralgia in the spinal cord of diabetic rats

    Neuroscience

  5. Metformin decreases inflammation in human cells (cells from healthy donors).

    “it exerted both anti-inflammatory and anti-autophagic effects on these cells, as evidenced by downregulation of IL-6 and MAPLC3 expression”

    Cellscells from healthy donorsnormal colonocytes

    Effects of metformin on cell viability and inflammatory status of human colonocytes: an in vitro preliminary analysis

    Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

  6. Metformin decreases inflammation.

    “the reduction of oxidative stress and inflammatory mediators”

    Reviewarticular cartilage

    Exploring the therapeutic applications of metformin in articular cartilage repair: mechanistic insights and translational perspectives

    Frontiers in immunology

  7. Metformin decreases inflammation in ICV-STZ-treated rats.

    “suppressed TNF-α, IL-1β, and iNOS expression”

    Animalsin ICV-STZ-treated ratshippocampus2 g/L12 weeksmales

    Hippocampal Klotho expression is associated with the neuroprotective effects of metformin against ICV-STZ-induced cognitive deficits

    European journal of pharmacology

  8. Metformin decreases inflammation (as reported in studies cited by the review).

    “metformin suppresses neuroinflammation by inhibiting the NF-κB signaling pathway and the NLRP3 inflammasome”

    Reviewas reported in studies cited by the review

    Metformin in Neurodegenerative Diseases: Mechanisms and Therapeutic Implications

    Current neuropharmacology

  9. Metformin decreases inflammation in rats (LPS-induced).

    “attenuating LPS-induced oxidative stress and inflammatory damage in placental tissue and trophoblast cells.”

    AnimalsLPS-inducedplacentafemales

    Combined treatment with metformin and melatonin improves placental mitochondrial function via the AMPK/SIRT3 pathway in an LPS-induced model of preeclampsia

    European journal of pharmacology

  10. Metformin decreases inflammation.

    “Metabolic modulators such as metformin and rapamycin attenuate inflammatory signaling”

    Review

    Inflammaging: Experimental Insights and Translational Advances

    European journal of immunology

All 11

More on Metformin

Caloric restriction

downin mice2downin reviews2downin rats1downin rhesus monkeys1

6 studies
  1. Caloric restriction decreases type I interferon signaling in rhesus monkeys following SIV infection.

    “CR reduced acute viremia, dampened type I interferon signaling, and enhanced CD8+ T cell cycling in lymphoid tissues.”

    Animalsfollowing SIV infection30% caloric restriction

    Calorie restriction lowered early virus levels in macaques

    Cell reports

  2. Caloric restriction decreases inflammation in mice (initiated prior to tumor induction).

    “caloric restriction initiated prior to tumor induction elicited a program of protection during tumor progression that attenuated multi-tissue inflammatory and catabolic transcriptional responses, preserved lean mass, and prolonged survival”

    Animalsinitiated prior to tumor inductionmulti-tissue

    Caloric restriction delays cancer wasting in mice

    bioRxivPreprint

  3. Caloric restriction decreases inflammation.

    “Caloric restriction and intermittent fasting reduce inflammation and benefit joint and muscle health”

    Review

    Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation

    Annals of medicine

  4. Caloric restriction inhibits inflammation in mice.

    “Lifelong CR dynamically reprogrammed these trajectories, blunting mid-life inflammatory surges”

    Animalsliver

    Caloric restriction reshapes liver lipid profiles in mice

    Prostaglandins & other lipid mediators

  5. Caloric restriction decreases inflammation.

    “It has been shown to reduce the production of reactive oxygen species, attenuate oxidative stress, suppress chronic systemic inflammation”

    Review

    A Review on Calorie Restriction and Skin Aging

    Jurnal Biomedika dan Kesehatan

  6. Caloric restriction decreases inflammation in rats.

    “Molecular biological analyses showed that neuroinflammatory markers interleukin-6 and inducible nitric oxide synthase were reduced in the EE and CR groups”

    Animals8 weeksmales

    Effects of environmental enrichment and caloric restriction on hippocampal changes in early adult rats

    Journal of Korean biological nursing science

More on Caloric restriction

SGLT2 inhibitors

downin humans2downin reviews2downin human cells1

5 studies
  1. SGLT2 inhibitors are linked with lower NF-κB signaling in humans.

    “attenuation of inflammatory signaling (lower NF-κB and IL-6)”

    Humansaortic valve

    SGLT2-Inhibitors and Molecular Signatures of Aortic Valve Remodeling in Severe Aortic Stenosis: The Valve-AS Study

    JACC. Basic to translational science

  2. SGLT2 inhibitors decrease inflammation in human cells (HFpEF model).

    “A comprehensive microarray analysis demonstrated the activation of genes associated with fibrosis and inflammation in the HFpEF model and the anti-inflammatory effects of SGLT2i addition”

    CellsHFpEF modelhuman engineered heart tissue

    Modeling HFpEF with hiPSC-Derived Heart Tissue Uncovers the Mechanism of SGLT2 Inhibitors

    AHA Scientific Sessions 2026 abstract

  3. SGLT2 inhibitors inhibit pyroptosis.

    “In conclusion, the inhibition of pyroptosis constitutes an autonomous cytoprotective mechanism of SGLT2 inhibitors”

    Review

    EFFECT OF SGLT2 INHIBITORS ON MARKERS OF PYROPTOSIS AND RENAL INFLAMMATION IN DIABETIC NEPHROPATHY: A SYSTEMATIC REVIEW

    GSC Advanced Research and Reviews

  4. SGLT2 inhibitors inhibit inflammation in humans.

    “At the molecular level, SGLT2i attenuate cardiac inflammation, oxidative stress, and fibrosis.”

    Reviewheart

    Beyond Glycemic Control: Multi-pathway Cardioprotective Mechanisms of Selective Na+/glucose Co-transporter 2 Inhibitors with Emerging Implications for Atrial Fibrillation

    Current cardiology reviews

  5. SGLT2 inhibitors inhibit inflammation (pleiotropic effects described in review).

    “SGLT2is exert pleiotropic effects that encompass a wide range of metabolic, hormonal, hemodynamic, biochemical, and anti-inflammatory actions”

    Reviewpleiotropic effects described in review

    Type 2 Diabetes: Chronic Clinical Metabolic Effects of SGLT2 Inhibitors

    Handbook of experimental pharmacology

More on SGLT2 inhibitors

Aerobic exercise

downin mice4downin rats1

5 studies
  1. Aerobic exercise decreases inflammation in mice (HFpEF).

    “reduced pro-inflammatory cytokines”

    AnimalsHFpEFparaventricular nucleus and nucleus tractus solitarius

    Aerobic exercise ameliorates cardiac function in HFpEF mice by suppressing ALCAT1, neuroinflammation and oxidative stress in the paraventricular nucleus and nucleus tractus solitarius

    Brain, behavior, and immunity

  2. Aerobic exercise decreases inflammation in mice (naturally aging mice).

    “accompanied by alleviated neuroinflammation, improved learning and memory, and ameliorated brain aging-related phenotypes.”

    Animalsnaturally aging micecontinuous treadmill aerobic exercisehippocampus8 weeksmales

    Mechanistic Study on IRF7-mediated Regulation of Learning and Memory Function by Aerobic Exercise in Aged Mice

    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

  3. Aerobic exercise decreases inflammation in mice (aged mice).

    “aerobic exercise improves cognitive function and attenuates hippocampal neuroinflammation”

    Animalsaged micetreadmillhippocampus16-weekmales

    Exercise alleviates neuroinflammation and cognitive decline in aged mice via hepatic FGF21-driven microglial mitophagy

    Brain, behavior, and immunity

  4. Aerobic exercise decreases inflammation in APP/PS1 mice.

    “attenuated Aβ pathology, suppressed neuroinflammation, and improved mitochondrial integrity and bioenergetic function”

    Animalsin APP/PS1 micetreadmillbrain12 weeks

    Aerobic exercise combined with FK866 ameliorates Alzheimer's disease-like pathology in APP/PS1 mice with NAMPT abnormality

    Frontiers in immunology

  5. Aerobic exercise decreases inflammation in rats (myocardial infarction).

    “Moderate-intensity AE alleviates myocardial injury, inflammation, and oxidative stress, and promotes macrophage polarization toward the M2 phenotype in rats with MI.”

    Animalsmyocardial infarctionModerate-intensity8 weeks

    Aerobic exercise modulates macrophage polarization and promotes cardiac recovery after myocardial infarction in rats

    Journal of cardiothoracic surgery

More on Aerobic exercise

Semaglutide

downin mice2no changein mice1downin pigs1downin rats1

4 studies
  1. Semaglutide decreases inflammation in pigs (chronic ischemic heart disease with diet-induced metabolic syndrome).

    “Inflammatory signaling appeared mitigated, with semaglutide treatment associated with increased inhibitor of kappa B (IκB) expression (p=0.03)”

    Animalschronic ischemic heart disease with diet-induced metabolic syndromeischemic myocardium5 weeksn = 16

    Effects of Semaglutide on Myocardial Remodeling in a High-Fat Diet Swine Model of Chronic Ischemic Heart Disease

    AHA Scientific Sessions 2026 abstract

  2. Semaglutide decreases inflammation in mice after sequential doxorubicin and trastuzumab.

    “semaglutide mitigated inflammatory signalling across cardiac, hepatic, and renal tissues”

    Animalsafter sequential doxorubicin and trastuzumabheart, liver and kidney10 days

    GLP-1 receptor agonist reduces anthracycline– and trastuzumab–induced cardiac dysfunction and systemic hs-CRP, IL-1β and IL-6 in non-diabetic preclinical models

    ESC Congress 2026 abstract

  3. Semaglutide showed no clear effect on inflammation in mice after semaglutide withdrawal and weight regain; compared with chronically obese controls.

    “Visceral adipose inflammation fully reverted, with macrophage infiltration and inflammatory gene expression comparable to chronically obese controls.”

    Animalsafter semaglutide withdrawal and weight regain; compared with chronically obese controlsvisceral adipose tissuemales

    Transient Adipose Inflammatory Remodeling during High-Dose Semaglutide-Induced Weight Loss and Regain

    Endocrinology and metabolism (Seoul, Korea)

  4. Semaglutide decreases inflammation in mice (diet-induced obesity; during treatment).

    “During treatment, visceral adipose tissue exhibited marked reductions in pro-inflammatory macrophages, crown-like structures, and inflammatory gene expression”

    Animalsdiet-induced obesity; during treatmentvisceral adipose tissue60 nmol/kg every 3 days3 weeksmales

    Transient Adipose Inflammatory Remodeling during High-Dose Semaglutide-Induced Weight Loss and Regain

    Endocrinology and metabolism (Seoul, Korea)

  5. Semaglutide decreases inflammation in rats (nicotinamide-streptozotocin-induced diabetes).

    “SMG treatment was associated with lower levels of MDA, TNF-α, Bax, IL-6, COX-2, and Caspase-3”

    Animalsnicotinamide-streptozotocin-induced diabetesbrain1.44 mg/kgone month

    Semaglutide Attenuates Type 2 Diabetes-Induced Neurotoxicity by Modulating Neuroinflammation, Oxidative Stress, and Neuroapoptosis

    Life (Basel, Switzerland)

More on Semaglutide

Fecal microbiota transplantation

downin mice2upin mice2downin reviews1

4 studies
  1. Fecal microbiota transplantation decreases inflammation in mice.

    “whereas transplantation of microbiota from young donors partially reversed these abnormalities in aged mice.”

    Animalsmicrobiota from young donors

    Gut microbes from old mice impaired young mice’s hearts

    AHA Scientific Sessions 2026 abstract

  2. Fecal microbiota transplantation increases inflammation in mice.

    “Transfer of microbiota from old donors induced intestinal permeability, inflammatory activation, and cardiac dysfunction in young recipients”

    Animalsmicrobiota from old donors

    Gut microbes from old mice impaired young mice’s hearts

    AHA Scientific Sessions 2026 abstract

  3. Fecal microbiota transplantation activates NLRP3 inflammasome activation in mice (transplanted with ARHL patient fecal microbiota).

    “activation of NLRP3 inflammasome at spiral ligament (SLi)”

    Animalstransplanted with ARHL patient fecal microbiotagut microbiota from ARHL patientsspiral ligament

    Gut microbes from hearing loss patients trigger inner ear damage in young mice

    Research SquarePreprint

  4. Fecal microbiota transplantation decreases inflammation in sarcopenia.

    “suppression of chronic inflammation, and enhancement of mitochondrial function.”

    Reviewin sarcopenia

    Research progress of fecal microbiota transplantation in sarcopenia

    Practical Geriatrics

  5. Fecal microbiota transplantation decreases inflammation in aged mice after experimental SAH.

    “was associated with reduced neuronal injury, neutrophil infiltration, NET formation, and microglial inflammation;”

    Animalsin aged mice after experimental SAHbrainmales

    Role of gut microbiome modulation in the attenuation of aging-related neuroinflammation in early brain injury after subarachnoid hemorrhage

    Brain research

More on Fecal microbiota transplantation

Nicotinamide mononucleotide

downin mice2downin cells1upin mice1

4 studies
  1. Nicotinamide mononucleotide decreases inflammation in mice (acute kidney injury).

    “NMN-PEG was found to augment peroxisomal function in PTCs via ACAA1, leading to increased β-oxidation of LCFAs and VLCFAs to mitigate ferroptosis and inflammation.”

    Animalsacute kidney injuryPEGylatedproximal tubule cell

    Modified compound reduced acute kidney injury in mice

    International journal of biological sciences

  2. Nicotinamide mononucleotide increases inflammation in mice.

    “In males, but not females, NMN increased physical activity and boosted metabolic health, whilst also upregulating inflammatory pathways”

    Animalslong-termmales

    Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner

    Research SquarePreprint

  3. Nicotinamide mononucleotide decreases inflammation in cells (LPS challenge).

    “by concurrently suppressing cGAS-STING-mediated inflammation”

    CellsLPS challenge

    NMN mitigates LPS-induced liver injury by inhibiting ferroptosis via suppression of the cGAS-STING-ACSL4 axis

    Pharmacological research

  4. Nicotinamide mononucleotide decreases inflammation in mice (chronic low-dose doxorubicin exposure).

    “Resveratrol and NMN preserve mitochondrial integrity and suppress inflammatory responses in renal tubules.”

    Animalschronic low-dose doxorubicin exposurerenal tubule

    Activation of the NAD⁺–Sirtuin Axis Protects Against Chronic Doxorubicin-Induced Subclinical Renal Tubular Injury Through Restoration of Mitochondrial Homeostasis and Suppression of Inflammation

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Nicotinamide mononucleotide

Diet

downin humans4

4 studies
  1. Diet protects against inflammation in humans.

    “The Mediterranean-style Japanese diet, a well-balanced diet, reduces the various disease risks by protecting us from the onset of chronic inflammation.”

    Review

    The Mediterranean-style Japanese Diet: A Systematic Review of the Recommendations for an Anti-aging Lifestyle

    Endocrine, metabolic & immune disorders drug targets

  2. Diet decreases inflammation in humans.

    “Dietary patterns such as Mediterranean, DASH, and plant-based diets improve lipid metabolism, attenuate inflammation, and enhance endothelial function.”

    Review

    Non-Pharmacological Strategies in Atherosclerotic Cardiovascular Disease: From Molecular Mechanisms to Clinical Integration

    Biomedicines

  3. Diet decreases inflammation in humans.

    “These changes were linked to improved metabolic and immune function, reduced inflammaging, lower frailty, and greater physical resilience.”

    Review

    How Gut Microbiota Influence Healthy Aging: Overview of Reviews

    Geriatrics (Basel, Switzerland)

  4. Diet decreases inflammation in humans.

    “These cognitive improvements are driven by interconnected physiological mechanisms, including reduced systemic inflammation”

    Review

    Dietary approaches to support cognition in older adults: a systematic review

    Frontiers in nutrition

More on Diet

Colchicine

downin humans1downin mouse cells1downin rats1

3 studies
  1. Colchicine inhibits inflammation in stable CAD with CHIP.

    “baseline correlations between clonal burden and inflammatory protein modules were markedly attenuated during colchicine exposure”

    Human trialin stable CAD with CHIPoral0.5 mg once daily4 weeksn = 48

    Colchicine alters protein networks in a coronary disease trial

    ESC Congress 2026 abstract

  2. Colchicine decreases inflammation in rats (spontaneously hypertensive rats).

    “reduced inflammation and extracellular matrix remodelling in mesenteric resistance arteries”

    Animalsspontaneously hypertensive ratsmesenteric resistance artery4 weeks

    Colchicine in chronic coronary artery disease: effects on vascular glucose uptake, inflammation, remodeling and blood pressure

    Cardiovascular research

  3. Colchicine inhibits NLRP3 inflammasome in mouse cells (Asxl1-mutant macrophages stimulated with LPS and nigericin).

    “Asxl1-mutant BMDMs exhibited enhanced NLRP3 inflammasome activation with increased IL-1β secretion, which was suppressed by colchicine”

    CellsAsxl1-mutant macrophages stimulated with LPS and nigericinbone marrow-derived macrophage

    Blood-cell mutation worsened aortic aneurysms in mice

    ESC Congress 2026 abstract

More on Colchicine

Rapamycin

downin humans1downin reviews1

2 studies
  1. Rapamycin decreases inflammation in humans (APOE4 carriers).

    “shows that the E4(+) group exhibited significant post-treatment reductions in monocyte chemoattractant protein-1 (MCP-1), a key mediator of inflammation and tissue injury (−0.155; 95% CI: −0.307, −0.003, p = 0.046).”

    Human trialAPOE4 carriers4-weekn = 9

    Rapamycin increases brain blood flow in Alzheimer's gene carriers

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

  2. Rapamycin decreases inflammation.

    “Metabolic modulators such as metformin and rapamycin attenuate inflammatory signaling”

    Review

    Inflammaging: Experimental Insights and Translational Advances

    European journal of immunology

More on Rapamycin

RBD5044

downin humans1

1 study
  1. RBD5044 decreases inflammation in humans.

    “broad downregulation of systemic inflammatory mediators, including cytokines and chemokines, was observed”

    Human trial

    Apolipoprotein and inflammatory biomarker changes following marked triglyceride reduction with the GalNAc-conjugated APOC3 siRNA RBD5044

    ESC Congress 2026 abstract

More on RBD5044

Low-calorie diet

downin humans1

1 study
  1. Low-calorie diet decreases inflammation in humans (followed by 6-month dietary intervention).

    “Weight loss significantly improved body composition, insulin sensitivity, inflammation and SCORE2.”

    Human trialfollowed by 6-month dietary intervention8 weeks plus 6 monthsn = 66

    Integrated adipose tissue transcriptomic and miRNA remodeling identifies molecular pathways associated with residual cardiovascular risk after weight loss

    Cardiovascular diabetology

More on Low-calorie diet

Cardiovascular exercise

downin humans1

1 study
  1. Cardiovascular exercise decreases inflammation in humans (early subacute phase after first-ever ischemic stroke; compared with standard care).

    “When introduced in the early subacute phase of stroke recovery, moderate-to-vigorous CE mitigates increases in inflammation, but the effect differs across mediators.”

    Human trialearly subacute phase after first-ever ischemic stroke; compared with standard careserummoderate-to-vigorous8 weeksn = 71

    Cardiovascular exercise mitigates inflammation in the early subacute phase of stroke recovery: a secondary analysis of a randomized controlled trial

    Brain, behavior, & immunity - health

More on Cardiovascular exercise

All 280

Effects

67

Cellular senescence

upin reviews2mediatesin cells1mediatesin mice1

4 studies
  1. IL-1 signaling mediates cellular senescence in mice (macrophage-to-fibroblast pro-senescent signaling).

    “macrophages, which transmit pro-senescent signals to uterine fibroblasts through IL-1β/IL-1R signaling”

    Animalsmacrophage-to-fibroblast pro-senescent signaling

    Prostaglandin E2 drives cellular senescence and scar fibrosis after cesarean section in mice

    EMBO molecular medicine

  2. cGAS–STING signaling increases cellular senescence.

    “dysregulated cGAS-STING signaling has emerged as an important driver of cellular senescence”

    Review

    The cGAS-STING pathway in inflammaging and neuroinflammation

    Science China. Life sciences

  3. cGAS–STING signaling mediates cellular senescence in cells (downstream of defective mitophagy and mitochondrial DNA leakage).

    “This defective mitophagy promotes mitochondrial DNA leakage and subsequent activation of the cGAS-STING pathway, ultimately driving cardiac senescence.”

    Cellsdownstream of defective mitophagy and mitochondrial DNA leakageheart

    CDK4/MERCs/PINK1 Axis Drives PFOA/HFPO-TA-Induced Cardiac Senescence via Mitophagy Defect and cGAS-STING Activation: In Vitro Amelioration by Cycloastragenol

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  4. cGAS–STING signaling induces cellular senescence.

    “its role in driving cellular senescence and the senescence-associated secretory phenotype (SASP)”

    Review

    The role and mechanisms of the cGAS-STING signaling pathway in age-related pathophysiological processes: challenges and therapeutic strategies

    Biochemical pharmacology

More on Cellular senescence

Senescence-associated secretory phenotype (SASP)

upin reviews2upin mice1

3 studies
  1. NF-κB signaling induces senescence-associated secretory phenotype (SASP) in mice.

    “Astrocytic NF-κB activation in young mice was able to mimic premature SASP formation but repressed Notch signaling in parallel.”

    Animalsastrocyte

    Aging mouse brains show opposing shifts in two cell signals

    Nucleic acids research

  2. cGAS–STING signaling increases senescence-associated secretory phenotype (SASP).

    “the overactivation of the cGAS-STING pathway is the core molecular mechanism driving the senescence-associated secretory phenotype (SASP)”

    Review

    Mitochondrial homeostasis and aging: the mtDNA-cGAS-STING axis

    Frontiers in immunology

  3. cGAS–STING signaling activates senescence-associated secretory phenotype (SASP).

    “damaged mitochondrial DNA leaks into the cytosol to activate the cyclic GMP-AMP synthase-stimulator of interferon genes pathway, amplifying the senescence-associated secretory phenotype”

    Review

    Mitochondria-Targeted Natural-Derived Compounds in Cellular Senescence: Mechanisms, Therapeutic Potential, and Future Directions

    Biology

More on Senescence-associated secretory phenotype (SASP)

Biological age

upin humans1mediatesin humans1upin reviews1

3 studies
  1. Inflammation is linked with biological age in humans (partially mediating the associations between metals and aging).

    “Inflammation and oxidative stress were found to partially mediate the associations between metals and aging.”

    Humanspartially mediating the associations between metals and aging

    Associations of single and combined exposure to plasma metals with biological aging in Chinese adults: Mediation by inflammation and oxidative stress and moderation by diabetes

    Journal of hazardous materials

  2. Inflammation increases biological age in PLWH.

    “drive accelerated and accentuated biological ageing in PLWH”

    Reviewin PLWH

    Ageing with HIV Clinical and Organisational Challenges of Care

    Journal of Education Health and Sport

  3. Inflammation increases biological age.

    “sustained inflammatory signaling accelerates biological aging through five interconnected pathways”

    Review

    High-fructose diet-induced gut dysbiosis as a mechanistic driver of chronic inflammation and accelerated biological aging: a comprehensive review

    Frontiers in microbiology

Cardiometabolic multimorbidity

mediatesin humans2

2 studies
  1. Inflammation is linked with cardiometabolic multimorbidity in humans (1.8% mediated through CRP).

    “systemic inflammation (CRP) exerted a marginal mediating effect (1.8%)”

    Humansmediation of the association between relative handgrip strength decline and cardiometabolic multimorbidityn = 6,839

    Grip strength measure linked to heart and metabolic conditions

    3 Biotech

  2. Inflammation mediates cardiometabolic multimorbidity in humans.

    “ultimately contribute to the development of both frailty and multiple cardiometabolic diseases by exacerbating chronic inflammation.”

    Review

    Research progress on the shared pathogenesis of frailty and cardiometabolic multimorbidity

    Practical Geriatrics

More on Cardiometabolic multimorbidity

Frailty

mediatesin humans1upin humans1

2 studies
  1. Inflammation mediates frailty in humans.

    “ultimately contribute to the development of both frailty and multiple cardiometabolic diseases by exacerbating chronic inflammation.”

    Review

    Research progress on the shared pathogenesis of frailty and cardiometabolic multimorbidity

    Practical Geriatrics

  2. Inflammation increases frailty in humans.

    “largely underpinned by oxi-inflammaging occurring at the cellular level, ultimately leading to progression of frailty”

    Review

    Cardiovascular frailty - an emerging frailty phenotype

    Journal of human hypertension

Mortality

mediatesin humans2

2 studies
  1. Inflammation is linked with mortality in humans (association between blood selenium and all-cause mortality in CKM syndrome) (3.57 to 5.29% mediated proportion).

    “Mediation analysis revealed that NLR, MLR, NMLR, and SIRI partially mediated the association between blood selenium and all-cause mortality, and the mediated proportions were relatively modest (ranging from 3.57 to 5.29%).”

    Humansassociation between blood selenium and all-cause mortality in CKM syndromen = 6,072

    Association Between Blood Heavy Metals and Selenium with All-Cause Mortality in Cardiovascular-Kidney-Metabolic Syndrome Populations: Exploring the Mediating Effects of Inflammatory Biomarkers

    Cardiovascular toxicology

  2. Inflammation is linked with mortality in humans (2.33–23.5% mediated).

    “Systemic inflammation mediated 2.33-23.5% of the mortality risk associated with DunedinPoAm, driven by CD4 + T cells, B cells, CRP and comprehensive inflammatory indices.”

    HumansMediation of the association between DunedinPoAm and mortality, estimated using Bayesian mediation frameworksMean follow-up 18.5 ± 1.29 yearsn = 2,532

    Inflammation mediates the Pace of aging based on DNA methylation on mortality from NHANES 1999-2002: a national prospective cohort study

    Clinical epigenetics

Atherosclerosis

upin humans1upin reviews1

2 studies
  1. Inflammation increases atherosclerosis.

    “The latter two processes are major promoters of the onset and progression of atherosclerosis.”

    Review

    Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review

    Medicina (Kaunas, Lithuania)

  2. Inflammation increases atherosclerosis in humans (estrogen decline after menopause).

    “chronic inflammation, which in turn promotes atherosclerosis, osteoporosis, and cognitive decline.”

    Reviewestrogen decline after menopausefemales

    The Interplay of Aging and the Immune System

    Missouri medicine

More on Atherosclerosis

Physical function

downin humans2−85% studies

2 studies
  1. Inflammation impairs physical function in humans.

    “This cycle may first impair muscle quality and contractile performance, resulting in early muscle weakness, and subsequently promote myofiber atrophy, fibrosis, fatty infiltration and overt functional decline.”

    Review

    The ageing microenvironment in sarcopenia: early alterations and targeted therapeutic strategies

    Frontiers in immunology

  2. Inflammation impairs physical function in humans (community-dwelling older adults) (85% of studies).

    “The majority of studies (85%) reported a statistically significant association between higher inflammation levels and poorer PP.”

    Reviewcommunity-dwelling older adults

    What is the impact of CRP, hs-CRP, IL-6, IL-10, and TNFα in physical performance in community-dwelling older adults: a systematic review

    BMC geriatrics

Axonal outgrowth

downin human cells1downin mouse cells1

1 study
  1. cGAS–STING signaling decreases axonal outgrowth in mouse cells (STING activation in macrophages in co-culture).

    “Conversely, activation of STING in macrophages suppressed axonal outgrowth in both human-derived and mouse neurons.”

    CellsSTING activation in macrophages in co-cultureneuron

    Inhibiting an immune signal improved nerve regrowth in aged mice

    Journal of translational medicine

  2. cGAS–STING signaling decreases axonal outgrowth in human cells (STING activation in macrophages in co-culture).

    “Conversely, activation of STING in macrophages suppressed axonal outgrowth in both human-derived and mouse neurons.”

    CellsSTING activation in macrophages in co-cultureneuron

    Inhibiting an immune signal improved nerve regrowth in aged mice

    Journal of translational medicine

Antibody secretion

is required forin human cells1

1 study
  1. TNF signaling is required for antibody secretion in estradiol-treated ASCs from young adult females.

    “Pharmacological inhibition of either NF-κB or TNF signaling blocked the ability of E2 to upregulate antibody secretion”

    Cellsin estradiol-treated ASCs from young adult females

    Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-κB and TNF signaling in B cells

    mBio

  2. NF-κB signaling is required for antibody secretion in estradiol-treated ASCs from young adult females.

    “Pharmacological inhibition of either NF-κB or TNF signaling blocked the ability of E2 to upregulate antibody secretion”

    Cellsin estradiol-treated ASCs from young adult females

    Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-κB and TNF signaling in B cells

    mBio

All 67

Upstream

148

Senescence-associated secretory phenotype (SASP)

upin reviews17upin humans2

19 studies
  1. Senescence-associated secretory phenotype (SASP) increases inflammation (Time- and context-dependent effects).

    “The senescence-associated secretory phenotype can propagate inflammation, matrix remodeling, and secondary senescence”

    ReviewTime- and context-dependent effects

    Cellular Senescence Phenotypes in Cardiovascular Aging: Mechanisms and Therapeutic Potential

    Clinical interventions in aging

  2. Senescence-associated secretory phenotype (SASP) increases inflammation (atherosclerosis).

    “The senescence-associated secretory phenotype (SASP) promotes vascular inflammation, extracellular matrix remodelling, and impaired clearance of apoptotic cells.”

    Reviewatherosclerosisvasculature

    CELLULAR SENESCENCE IN ATHEROSCLEROSIS: MOLECULAR MECHANISMS, PATHOGENIC SIGNIFICANCE, AND EMERGING PHARMACOLOGICAL STRATEGIES

    INTERNATIONAL JOURNAL OF ADVANCED SCIENTIFIC AND TECHNICAL RESEARCH

  3. Senescence-associated secretory phenotype (SASP) increases inflammation (sarcopenia).

    “SASP can promote persistent local inflammation, changes in immune cell function, and the spread of the senescent phenotype”

    Reviewsarcopenia

    Research advances in the senescence-associated secretory phenotype-mediated immune-inflammatory network in sarcopenia

    Geriatrics Research

  4. Senescence-associated secretory phenotype (SASP) increases inflammation (when senescent cells persist in cancer).

    “it can also promote chronic inflammation, immune suppression, stromal remodeling, recurrence and resistance when senescent cells persist.”

    Reviewwhen senescent cells persist in cancer

    Reshaping the tumor immune microenvironment via therapy-induced senescence: senescence-associated secretory phenotype networks and senolytic strategies

    Molecular biology reports

  5. Senescence-associated secretory phenotype (SASP) induces inflammation.

    “the senescence-associated secretory phenotype (SASP) orchestrates inflammaging and reprograms the CRC microenvironment via pro-inflammatory cytokines, chemokines, and growth factors.”

    Reviewcolorectal cancer microenvironment

    Immunosenescence in colorectal cancer: Interplay of microbiota, inflammaging, and metabolic reprogramming

    Cytokine & growth factor reviews

  6. Senescence-associated secretory phenotype (SASP) increases inflammation.

    “the secretion of the senescence-associated secretory phenotype (SASP), rich in proinflammatory cytokines and metalloproteinases, drive inflammaging and oxinflammaging.”

    Reviewskin

    Cutaneous inflammaging and cellular senescence: Molecular mechanisms of inflammatory skin aging and therapeutic targets

    Research Society and Development

  7. Senescence-associated secretory phenotype (SASP) increases inflammation in oral lichen planus.

    “senescent mesenchymal cells may amplify inflammation via SASP”

    Reviewin oral lichen planus

    T-cell senescence and immunosenescence in chronic oral mucosal inflammatory diseases: mechanisms and therapeutic implications

    Journal of oral microbiology

  8. Senescence-associated secretory phenotype (SASP) increases inflammation.

    “facilitates SASP activation, leading to neuroinflammation and neurodegeneration.”

    Reviewbrain

    Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration

    Brain sciences

  9. Senescence-associated secretory phenotype (SASP) induces inflammation.

    “exhibit a senescence-associated secretory phenotype that can lead to propagation of inflammation, modification of immune-cell function, induce secondary senescence and promote extracellular matrix remodeling”

    Reviewkidney allograft

    Senescent Cells in Kidney Transplantation: Hidden Drivers of Graft Aging, Inflammation, and Long-Term Dysfunction

    KIDNEYS

  10. Senescence-associated secretory phenotype (SASP) increases inflammation.

    “persistent activity drives chronic low-grade inflammation and contributes to age-related diseases.”

    Review

    The vicious cycle of SASP and inflammaging promotes aging and age-related diseases

    Communications biology

All 19

More on Senescence-associated secretory phenotype (SASP)

Cellular senescence

upin reviews4upin humans2upin E. caballus cells1

7 studies
  1. Cellular senescence increases inflammation (persistent senescent hepatic stellate cells).

    “persistent senescent HSCs can promote inflammation and immune escape.”

    Reviewpersistent senescent hepatic stellate cellshepatic stellate cell

    Bidirectional cellular senescence crosstalk in MASLD: mechanisms, disease progression, and treatment strategies

    Frontiers in endocrinology

  2. Cellular senescence increases inflammation.

    “senescent cells promote chronic inflammation, fibrosis, impaired regeneration, and metabolic dysfunction”

    Reviewskeletal muscle

    Cellular Senescence in Skeletal Muscle: Molecular Mechanisms, Physiological Consequences, and Therapeutic Opportunities

    Annual review of physiology

  3. Cellular senescence increases inflammation in MASLD.

    “Cellular senescence drives inflammation and fibrosis progression in metabolic dysfunction-associated steatotic liver disease (MASLD) through the senescence-associated secretory phenotype (SASP).”

    Reviewin MASLD

    Biomarker-Guided, Stage-Specific Senotherapy for Metabolic Dysfunction-Associated Steatotic Liver Disease

    Aging and disease

  4. Cellular senescence increases inflammation (failed resolution of repair-associated senescence).

    “Once established beyond the adaptive repair window, this state can perpetuate inflammation, fibrosis and functional decline even after the original injury has diminished.”

    Reviewfailed resolution of repair-associated senescence

    Senescent repair memory in chronic disease: Failed resolution as a driver of persistent organ dysfunction

    Ageing research reviews

  5. Cellular senescence increases inflammation.

    “The accumulation of senescent cells in the nervous system exacerbates neuroinflammation, impairs neuronal function, and accelerates tissue degeneration, all of which are key features of NDDs.”

    Reviewnervous system

    Targeting cellular senescence with Traditional Chinese Medicine: advances in neurodegenerative disorder treatment

    Frontiers in neurology

  6. Cellular senescence induces inflammation in E. caballus cells (tenocyte senescence).

    “senescence in tenocytes drives inflammation, hypercontractility, and dysregulation of tendon matrix components.”

    Cellstenocyte senescencetenocyte

    Senescent tenocytes drive an age-associated loss of cell-extracellular matrix homeostasis, which can be partially restored using dihydroresveratrol

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  7. Cellular senescence increases inflammation in neutrophilic asthma.

    “the accumulation of aging-related cells releases the senescence-associated secretory phenotype (SASP), which appears to play a pivotal role in establishing and amplifying neutrophilic inflammation.”

    Reviewin neutrophilic asthma

    From inflammaging to steroid resistance: reframing the pathogenesis of neutrophilic asthma

    Frontiers in allergy

More on Cellular senescence

Mitochondrial dysfunction

upin reviews4upin mice1

5 studies
  1. Mitochondrial dysfunction increases inflammation.

    “dysfunctional mitochondria act as both initiators and amplifiers of senescence and inflammation”

    Review

    Mitochondrial dysfunction and inflammaging: a mechanistic bridge between bioenergetic failure and senescence

    GeroScience

  2. mitochondrial dysfunction induces inflammation in mice (through metabolic reprogramming of the myeloid immune subset).

    “induces immune dysregulation and inflammation through metabolic reprogramming of the myeloid immune subset”

    Animalsthrough metabolic reprogramming of the myeloid immune subsetmyeloid immune subset

    Gut microbes fuel aging tied to mitochondrial defects in mice

    bioRxivPreprint

  3. mitochondrial dysfunction activates inflammation.

    “damaged mitochondria produce more ROS and release mtDNA, activating inflammatory pathways such as cGAS-STING and NLRP3.”

    Review

    Oxidative Stress and Mitochondrial Dysfunction: Molecular Interplay, Disease Mechanisms, Biomarkers, and Emerging Therapeutic Strategies: A Comprehensive Review

    World Journal of Chemical and Pharmaceutical Sciences

  4. mitochondrial dysfunction induces inflammation.

    “These disturbances drive oxidative damage, metabolic reprogramming, impaired mitophagy, and the release of pro-inflammatory signals known as mtDAMPs.”

    Review

    Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies

    Pharmacological research

  5. mitochondrial dysfunction induces inflammation.

    “These damaged mitochondria can subsequently release damage-associated molecular patterns (DAMPs), which activate innate immune pathways and may trigger a chronic low-grade inflammatory state, ultimately contributing to cellular senescence”

    Review

    Corticotropin-releasing factor (CRF) in brain aging: from mitochondrial dysfunction to inflammaging

    Frontiers in aging neuroscience

Mitochondrial DNA

upin reviews2upin cells1upin mouse cells1

4 studies
  1. Mitochondrial DNA activates cGAS–STING signaling in mouse cells (extracellular mitochondrial DNA released from senescent cardiomyocytes).

    “This extracellular mtDNA engaged the cGAS-STING pathway in macrophages, amplifying cardiac inflammation.”

    Cellsextracellular mitochondrial DNA released from senescent cardiomyocytesmacrophage

    Lowering a protein improved heart relaxation in aged mice

    Cell biology and toxicology

  2. mitochondrial DNA activates cGAS–STING signaling in cells.

    “The internalized mtDNA activates the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) cytosolic DNA-sensing pathway”

    Cells

    Adipose-cartilage communication via EV-Mito-mtDNA signaling promotes osteoarthritis progression

    Science advances

  3. mitochondrial DNA activates cGAS–STING signaling during aging.

    “the aberrant release of endogenous mitochondrial DNA (mtDNA) is a key trigger for the activation of the cGAS-STING innate immune pathway”

    Reviewduring aging

    Mitochondrial homeostasis and aging: the mtDNA-cGAS-STING axis

    Frontiers in immunology

  4. mitochondrial DNA activates cGAS–STING signaling.

    “the release of mitochondrial DNA, vesicles, and peptides activates innate immune sensors such as the cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthase-stimulator of interferon genes (cGAS-STING) pathway”

    Review

    Understanding cardiovascular aging as a disorder of mitochondrial network

    The journal of cardiovascular aging

More on Mitochondrial DNA

SIRT1

downin reviews3

3 studies
  1. SIRT1 decreases inflammation.

    “SIRT1 exerts vasculoprotective effects through deacetylation of key transcription factors leading to reduced inflammation”

    Review

    SIRT1 in Cardiometabolic Pathophysiology: A Narrative Review

    Cells

  2. SIRT1 inhibits NF-κB signaling.

    “SIRT1, a NAD + ‐dependent deacetylase acting as a negative regulator of NF‐κB transcription.”

    Reviewbone

    Resveratrol Modulates Bone Metabolism Through SIRT1‐Mediated NF‐κB Inhibition: Molecular Mechanisms and Therapeutic Implications

    Cell biochemistry and function

  3. SIRT1 decreases inflammation (SIRT1 modulation in experimental models).

    “SIRT1 modulation can improve endothelial function and mitochondrial homeostasis, attenuate oxidative stress, inflammation, and vascular remodeling”

    ReviewSIRT1 modulation in experimental models

    Sirtuin-1 in Hypertension: Linking Oxidative Stress and Mitochondrial Dysfunction to Vascular Aging and Therapeutic Potential

    Antioxidants (Basel, Switzerland)

More on SIRT1

APOE

upin mice2upin humans1

3 studies
  1. APOE is linked with higher inflammation in humans (independent of AD diagnosis).

    “We identify a conserved, allele dose-dependent pro-inflammatory immune protein signature across peripheral and central tissues independent of AD diagnosis.”

    Humansindependent of AD diagnosis

    Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. APOE increases inflammation in mice (ApoE4/4 knock-in mice).

    “Here we show that ApoE4 mice develop severe hepatic steatosis, neuroinflammation and lipid raft rigidification”

    AnimalsApoE4/4 knock-in micebrainfemales

    Dietary fat rebalanced brain membrane fats in mice

    Molecular biomedicine

  3. APOE increases cGAS–STING signaling in mice (APOE4 compared with APOE3).

    “APOE4 brains exhibit increased cGAS expression and phosphorylation of STING, TBK1, and IRF3, together with elevated type I interferon and pro-inflammatory responses.”

    AnimalsAPOE4 compared with APOE3brain

    Gene variant linked to greater brain inflammation in aging mice

    Free radical biology & medicine

More on APOE

Clonal hematopoiesis of indeterminate potential

upin reviews2upin humans1

3 studies
  1. Clonal hematopoiesis of indeterminate potential increases inflammation (heart failure with preserved ejection fraction).

    “Mechanistically, CHIP promotes inflammatory signaling through activation of pathways such as the NLRP3 inflammasome and IL-1β/IL-6 axis.”

    Reviewheart failure with preserved ejection fraction

    Clonal Hematopoiesis and Inflammatory Pathways in Heart Failure with Preserved Ejection Fraction

    Current heart failure reports

  2. Clonal hematopoiesis of indeterminate potential induces inflammation in humans.

    “expansion of these mutant clones drives a systemic inflammatory state”

    Review

    EULAR Rheumatology Open Special Issue titled 'VSI: ATT2026': the role of clonal haematopoiesis in immunological and rheumatological diseases

    EULAR rheumatology open

  3. Clonal hematopoiesis of indeterminate potential increases inflammation.

    “age-related Clonal Hematopoiesis of Indeterminate Potential (CHIP) amplifies this inflammatory dysregulation.”

    Review

    The immunological imprint of recurrent periodontitis: From local tissue memory to central trained immunity

    Periodontology 2000

More on Clonal hematopoiesis of indeterminate potential

Age

no changein humans1upin mice1upin reviews1

3 studies
  1. age was not clearly linked with inflammation in humans.

    “while no significant differences in pro-inflammatory status were identified.”

    Humans

    Age-related characteristics of metabolic phenotypes and proinflammatory status in patients with normal and overweight body mass

    Advances in gerontology = Uspekhi gerontologii

  2. Age increases inflammation in mice (C12FDG-positive FAPs in regenerating muscle).

    “C12FDG-positive fibro-adipogenic progenitors (FAPs) shifted toward an inflammatory and immune-associated state”

    AnimalsC12FDG-positive FAPs in regenerating muscleskeletal muscle

    Aging reshapes injury-induced senescence into distinct stromal senotypes during muscle regeneration

    Research SquarePreprint

  3. Age increases inflammation.

    “As organisms age, this triadic equilibrium destabilizes, leading to reduced microbial diversity, compromised barrier integrity and function, and chronic inflammation that accelerates age-related pathologies.”

    Review

    From cooperation to collapse: the diet-microbiota-host gene triad in disease and aging

    Frontiers in microbiomes

SERPINE1

upin cells1upin reviews1

2 studies
  1. SERPINE1 activates cGAS–STING signaling in cells (at least partly through LRP1).

    “SERPINE1 triggered cytosolic mtDNA release to activate the cGAS-STING pathway at least in part through the LRP1 receptor”

    Cellsat least partly through LRP1fibroblast

    Protein-blocking drug eased intestinal inflammation in mice

    Biology direct

  2. SERPINE1 increases inflammation.

    “SERPINE1 also contributes to senescence-associated inflammatory signaling, which may further support the maintenance of the senescent phenotype.”

    Review

    SERPINE1 (PAI-1) Regulation in Mechanotransduction-Associated Cellular Senescence

    Journal of cellular biochemistry

More on SERPINE1

SIRT3

downin mice1downin mouse cells1

2 studies
  1. SIRT3 inhibits cGAS–STING signaling in mouse cells (PDF treatment).

    “SIRT3 blocked mtDNA release by inhibiting BNIP3-mediated mPTP opening, thereby suppressing cGAS-STING activation and macrophage senescence.”

    CellsPDF treatmentRAW264.7 macrophages

    A protein reduced dialysis-related tissue scarring in mice

    Frontiers in cell and developmental biology

  2. SIRT3 decreases inflammation in mice.

    “SIRT3, a mitochondrial deacetylase highly expressed in HSCs but reduced during aging, suppresses the HSC response to aging that drives maladaptive trained immunity, chronic inflammation and tissue functional decline in mice.”

    Animalshematopoietic stem cells

    Trained immunity links hematopoietic stem cell aging to aging-associated inflammation

    Nature aging

More on SIRT3

All 148

Associations

97

Female sex

upin mice3

3 studies
  1. Female sex is associated with inflammation in mice.

    “females, which also displayed a heightened inflammatory milieu and increased frequencies of activated B cells.”

    Animalsfemale versus males

    Sex and Age Shape the Expansion, Phenotype, and Autoreactive Potential of CD11c ⁺ Double‐Negative B Cells in Mice

    European journal of immunology

  2. Female sex is associated with inflammation in mice (aging and amyloid pathology).

    “females exhibiting greater disease-associated microglia (DAM) proportions and reactivity alongside enhanced neuroinflammatory and interferon-related signaling.”

    Animalsaging and amyloid pathologybrainfemale versus males

    Brain immune cells react more strongly in female mice

    bioRxivPreprint

  3. Female sex is associated with inflammation in mice (Prph2KI/WT mice; compared with males).

    “From the earliest stages of the disease, females exhibited greater and sustained inflammatory activation”

    AnimalsPrph2KI/WT mice; compared with malesretinafemales

    Age and sex shaped damage to the retina in mutant mice

    Cell death discovery

Age

mixedin silico1upin mice1upin reviews1

3 studies
  1. Age is associated with inflammation (Alzheimer's disease).

    “Age in particular emerges as a major determinant that biases immune responses from earlier regulatory states toward later maladaptive inflammation”

    ReviewAlzheimer's disease

    Age‐linked biological context shapes adaptive immunity in Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Age is associated with type I interferon signaling in silico (Peaked at 12 months and resolved by 24 months).

    “A cochlea-wide type I interferon response peaked at 12 months and resolved by 24.”

    In silicocochlea

    A time-resolved single-nucleus atlas of cochlear aging reveals biphasic inflammaging and Tbx2-dependent inner hair cell maintenance

    Hearing research

  3. Inflammation is associated with age in mice (age-dependent associations in spatial transcriptomic data).

    “alongside age-dependent inflammatory and metabolic associations”

    Animalsage-dependent associations in spatial transcriptomic dataovary

    Paired-surface spatial mechanomics links tissue stiffness maps to spatial transcriptomics

    bioRxivPreprint

Cellular senescence

upin reviews2mixedin human cells1

3 studies
  1. Cellular senescence is associated with inflammation (persistent cellular senescence during wound healing).

    “its persistence, in contrast, has been associated with prolonged inflammation, proteolytic disorganization, and loss of regenerative capacity.”

    Reviewpersistent cellular senescence during wound healingskin

    Fibroblast senescence and extracellular matrix remodeling in cutaneous wound healing: Potential of molecular biomarkers in the early identification of wounds at risk of becoming chronic

    Revista Tópicos.

  2. Cellular senescence is associated with inflammation in human cells (influenza A virus-infected idiopathic pulmonary fibrosis fibroblasts).

    “senescent IPF fibroblasts displayed an altered inflammatory response.”

    Cellsinfluenza A virus-infected idiopathic pulmonary fibrosis fibroblastsprimary lung fibroblast

    Senescent human lung cells show altered virus defenses

    Aging cell

  3. cGAS–STING signaling is associated with cellular senescence.

    “The innate immune cGAS-STING signaling pathway, acting as a key sensor of endogenous damage, has emerged as a nexus linking cellular senescence to chronic inflammation.”

    Review

    Mechanisms of cGAS-STING-mediated chronic inflammation and targeted interventions in brain aging

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

More on Cellular senescence

Cardiovascular disease

upin humans2upin reviews1

3 studies
  1. Inflammation is associated with cardiovascular disease in people with HIV on antiretroviral therapy.

    “Neurocognitive disorders, liver disease, lung disease, cardiovascular disease, and frailty are all elevated, and linked to the viral reservoir through chronic inflammation and direct viral mechanisms.”

    Reviewin people with HIV on antiretroviral therapy

    The interaction of comorbidities, aging, and HIV persistence in tissues

    Current opinion in HIV and AIDS

  2. cGAS–STING signaling is associated with cardiovascular disease.

    “is significantly activated in a variety of cardiovascular diseases including hypertension,coronary heart disease,and cardiac hypertrophy”

    Review

    Mechanism of Association Between Abnormity of Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase-Stimulator of Interferon Gene Pathway and Cardiovascular Diseases and the Exercise Regulation:A Review

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

  3. Inflammation raises the risk of cardiovascular disease in humans (permissive metabolic environment).

    “metainflammation acts as a contributory driver of this transition; however, its pathogenic potential is realized only within a permissive metabolic environment”

    Reviewpermissive metabolic environment

    The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease

    Journal of inflammation research

More on Cardiovascular disease

Microbiome composition

upin humans2mixedin mice1

3 studies
  1. Microbiome composition is associated with inflammation in humans.

    “gut microbiota composition explained more variance than age for 97% of cytokines and 84% of physiological variables.”

    Humansn = 1,199

    Gut microbes predict inflammation better than age in adults

    Nature communications

  2. Microbiome composition is associated with inflammation in mice (AD mouse models).

    “microbiota-related factors may contribute to exercise-associated modulation of neuroinflammation, amyloid-β and tau pathology, and cognitive outcomes”

    ReviewAD mouse models

    Aerobic exercise and the gut-brain axis in Alzheimer's disease: Mechanistic perspectives, evidence appraisal, and future directions

    Ageing research reviews

  3. Microbiome composition is associated with inflammation in humans (dysbiosis involving bacteria, fungi, and cross-kingdom interactions).

    “Dysbiosis involves not only bacteria but also fungi and cross-kingdom interactions, which may be associated with barrier disruption, chronic inflammation, and malignant transformation.”

    Reviewdysbiosis involving bacteria, fungi, and cross-kingdom interactions

    Early esophageal squamous neoplasia and the microbiome: evidence, mechanisms, and early-detection potential

    Frontiers in microbiology

More on Microbiome composition

Older age

upin humans2

2 studies
  1. Older age is associated with inflammation in humans (comparable BMI (40 ±5 kg/m2)).

    “VAT from older adults exhibited increased expression of senescence-associated markers, including CDKN2A (p16INK4a) and CDKN1A (p21CIP1), as well as enhanced fibro-inflammatory and tissue-remodeling programs.”

    Humanscomparable BMI (40 ±5 kg/m2)omental visceral adipose tissue

    Older age linked to more signs of senescence in human fat

    bioRxivPreprint

  2. Older age is associated with inflammation in humans (atherosclerotic cardiovascular disease).

    “The significant increases (P≤0.05) in oxidized low-density lipoprotein, malondialdehyde, interleukin-1 alpha, and interleukin-1β concentrations in elderly patients compared to non-elderly patients.”

    Humansatherosclerotic cardiovascular diseaseserumn = 60

    Assessment of Interleukin-1 Alpha,Interleukin-1 Beta, and Oxidative Stress in Patients with Atherosclerotic Cardiovascular Disease in Thi-Qar, Iraq

    Medical Forum Monthly

Atherosclerosis

upin humans1upin silico1

2 studies
  1. Inflammation raises the risk of atherosclerosis in humans.

    “chronic low-grade inflammation, or “inflammaging,” is increasingly recognized as an important contributor to atherosclerosis and cardiovascular events in older adults.”

    Review

    Inflammaging and Acute Coronary Syndrome in Elderly Patients: Pathophysiological Mechanisms, Therapeutic Implications and Future Perspectives

    Life (Basel, Switzerland)

  2. Inflammation is associated with atherosclerosis in silico (hallmark enrichment and network proximity analysis).

    “biologically meaningful disease-associated processes, like "Loss of proteostasis" in Alzheimer's disease and "Chronic inflammation" in atherosclerosis as highly significant hallmarks.”

    In silicohallmark enrichment and network proximity analysis

    An integrated resource for systems-level analysis of aging hallmarks and associated genes

    Biogerontology

More on Atherosclerosis

Cognitive function

downin humans2

2 studies
  1. Inflammation is associated with cognitive function in humans.

    “Factor 4 (CCL4, CXCL1, S100A12) and Factor 5 (IL2, IL5, IL13, IL10, CSF2) were inversely associated with PACC scores.”

    HumansFactor 4 (CCL4, CXCL1, S100A12) and Factor 5 (IL2, IL5, IL13, IL10, CSF2) inversely associated with PACC scoresplasman = 334

    Exploratory factor and network analysis of 43 inflammatory plasma biomarkers and cognitive performance in Black adults

    Journal of Alzheimer's disease : JAD

  2. Inflammation predicts cognitive function in humans.

    “higher chronic inflammation, which in turn predicted worse cognitive function”

    Humans

    Exposure to stress across the life course and cognitive function: the role of chronic inflammation

    Aging & mental health

Mediterranean diet

mixedin humans1downin humans1OR 2.46

2 studies
  1. Mediterranean diet is linked with a lower risk of inflammation in humans (comparing better adherence (MED-DQI ≤ 7) vs lower adherence (MED-DQI ≥ 8)) (OR 2.46; 95% CI 1.01 to 6.02).

    “and higher odds of elevated inflammation (OR 2.46; 95% CI 1.01 to 6.02; p = 0.038).”

    Humanscomparing better adherence (MED-DQI ≤ 7) vs lower adherence (MED-DQI ≥ 8)malesn = 82

    Mediterranean diet adherence and systemic inflammation in people with HIV and PrEP users

    Frontiers in nutrition

  2. Mediterranean diet is associated with inflammation in systematic review and network analysis.

    “MedDiet may exert its health benefits through systems-level modulation of interconnected metabolic pathways, contributing to the regulation of inflammation, lipid metabolism and cardiovascular function.”

    Reviewin systematic review and network analysis

    Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress

    Frontiers in nutrition

More on Mediterranean diet

Dietary organosulfur-containing compounds

mixedin reviews1

1 study
  1. Dietary organosulfur-containing compounds are associated with inflammation.

    “DOSCs can attenuate oxidative damage, improve mitochondrial function, modulate inflammatory signaling, and enhance resilience against age‐related decline.”

    Review

    Dietary Organosulfur‐Containing Compounds (DOSCs) as Healthy Longevity Agents: Mechanisms, Evidence, and Future Perspectives

    Comprehensive reviews in food science and food safety

More on Dietary organosulfur-containing compounds

All 97

Funding

125 grants since 2016

National Institute on Aging$48.5MJapan Society for the Promotion of Science¥365MNational Cancer Institute$4.7M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Inflammation is associated with age in healthy postmenopausal women's ovaries and with mortality in people with chronic kidney disease. Exercise and several compounds reduce inflammation in naturally aged mice. A human trial reports reduced type I interferon signaling with metformin, whereas a trial of exercise plus cognitive-behavioral training shows no clear effect on inflammation.

  2. Summary rewritten as its findings changed.

    As it read before

    A human study links inflammation with higher mortality in people with chronic kidney disease. Studies in aged mice report reduced inflammation with soybean polysaccharide, hymecromone and Bifidobacterium pseudocatenulatum. A human trial reports reduced type I interferon signaling with metformin; other trials show no clear effect on inflammation with resveratrol or exercise plus cognitive-behavioral training.

  3. Summary rewritten as its findings changed.

    As it read before

    Inflammation is linked with higher mortality in people with chronic kidney disease and with epigenetic age in people with bipolar disorder. Aerobic exercise reduces hippocampal inflammation in naturally aging male mice. Human trials report reduced type I interferon signaling with metformin and reduced inflammation with rapamycin in APOE4 carriers, but no clear effect on inflammation with resveratrol.

  4. Summary rewritten as its findings changed.

    As it read before

    Ghrelin, soybean polysaccharide and telomeric antisense oligonucleotides reduce inflammation in aged mice. Human observational studies link inflammation with menopause and with epigenetic age in people with bipolar disorder. Human trials report reduced type I interferon signaling with metformin but no clear effect on inflammation with resveratrol or exercise plus cognitive-behavioral training.

  5. Summary rewritten as its findings changed.

    As it read before

    Inflammation is associated with older age in a human preprint and with epigenetic age in people with bipolar disorder; natural aging activates type I interferon signaling in mouse endothelial cells. Human trials report reduced inflammation with semaglutide and, in older individuals, zoster vaccination, but no effect with resveratrol or peanuts.

Latest

Postgraduate Medical Journal

One inflammation marker was slightly higher in older adults

Red blood cell sedimentation rate was 1.00 millimeter per hour higher per decade of age; other inflammation measures showed no age link.Red blood cell sedimentation rate was 1.00 millimeter per hour higher per decade of age; other inflammation measures showed no age link.

Cross-sectional · 5,510 peopleBiomarkers
bioRxiv

Drug improved the heart’s natural pacemaker function in rats

At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.At the acute endpoint, efsubaglutide alfa raised heart rate to 372.76 beats per minute versus 312.64 in rats with pacemaker dysfunction without the drug.

Preprint: rat studyInterventions

See all 34,417 papers on chronic inflammation